| ²é¿´: 4755 | »Ø¸´: 135 | ||||||||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û117´Î£¬×÷ÕßsakfyÔö¼Ó½ð±Ò 90.6 ¸ö | ||||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||||||
[×ÊÔ´]
¿¹ÒÖÓôÖ¢Ò©·ÖÎö±¨¸æÓ¢Îİ棨ÌÀÉ·͸2014Ä꣩
|
||||||||
| Depression has been treated with a number of blockbuster drugs, but these have been severely impacted by patent expiration. At its peak in 2003, the branded depression drug market was worth almost $15 billion, but by 2012 the market had lost almost a third of its value, with sales of $9.560 billion reported that year (see Figure 2). Consensus forecasts from Thomson Reuters Cortellis™ Competitive Intelligence anticipate an even steeper decline from 2013 to 2014, with 2014 forecast sales of $5.720 billion. The pharmacompanies have as yet been unable to produce new products that significantly differentiate themselves from generic formulations, resulting in the drop in market revenue we now see. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : SPOTLIGHT_ON_DEPRESSION-A_PHARMA_MATTERS_REPORT.pdf
2014-05-05 16:46:41, 443.5 K
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¾µä×ÊÔ´Ìû | »¯¹¤ | Ò½Ò©Êг¡ÐÅÏ¢»ã±à | Ò©Æ·Ñз¢ |
Éú»îŒ?Óà | ÉúÎïÖÆ¼Á |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
Çó26½ìaidd²©µ¼ÍƼö
ÒѾÓÐ4È˻ظ´
2026Éê²©ÍÆ¼ö
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ278È˻ظ´
һƪÀ©É¢Ä£Ð͵ÄNature Machine IntelligenceÂÛÎĺÍElsevierÉϵÄÉî¶ÈѧϰҩÎïÊé¼®
ÒѾÓÐ1È˻ظ´
CSC¸ÄÅÉ-²©Ê¿Éú½»Á÷·Ãѧ
ÒѾÓÐ19È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ0È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ1È˻ظ´
°ÍÀèÈø¿ËÀ×´óѧÓë¹ú¼ÒÁôѧ»ù½ðίºÏ×÷²©Ê¿Ñо¿ÉúÏîÄ¿-Ö¬ÖÊÄÉÃ×Ò©Îï/ÉúÎï²ÄÁÏ/¶à·ÓµÝËÍ
ÒѾÓÐ10È˻ظ´
ÖйúÒ©¿Æ´óѧ2026Èëѧ²©Ê¿£¬Ò©ÎïºÏ³ÉºÍÉè¼Æ¾Ñ飬·ÅÉ仯ѧ¼°·ÅÉäҽѧÑо¿
ÒѾÓÐ25È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
µ½ÃÀ¹úÑÐÐÞ¶þÄ꣬»¼ÓÐÒÖÓôÖ¢£¬ÄÜ´øÏà¹ØµÄÒ©Æ·Âð£¿
ÒѾÓÐ3È˻ظ´
µ½ÃÀ¹úÑÐÐÞ¶þÄ꣬»¼ÓÐÒÖÓôÖ¢£¬ÄÜ´øÏà¹ØµÄÒ©Æ·Âð£¿
ÒѾÓÐ4È˻ظ´
ÖÎÁÆÒÖÓôÖ¢Ò©ÎïÁÙ´²ÊÔÑé¼¼ÊõÖ¸µ¼ÔÔò(Õ÷ÇóÒâ¼û¸å)
ÒѾÓÐ28È˻ظ´
¡¶2012Äê¶ÈÖйúÒ©Æ·ÉóÆÀ±¨¸æ¡·Ó¢Îİæ--2012 China Drug Review Annual Report.
ÒѾÓÐ9È˻ظ´
Ò©Îï·ÖÎö·½·¨µÄ½¨Á¢--¼ò½é£¨Ó¢Îİ棩
ÒѾÓÐ15È˻ظ´
135Â¥2019-11-27 16:21:07













»Ø¸´´ËÂ¥
zhangl0782